Inhibitory_effect_of_sandostatin_on_secretion_of_luteinising_hormone_and_ovarian_steroids_in_polycystic_ovary_syndrome._Hyperinsulinism_accompanies_the_raised_luteinising_hormone_(LH)_concentrations_in_women_with_the_polycystic_ovary_syndrome_(PCOS)._Somatostatin_inhibits_insulin_and_LH_secretion_in_healthy_adults,_so_the_effect_of_treatment_with_a_long-acting_somatostatin_analogue_('Sandostatin')_on_gonadotropin_and_androgen_secretion_in_PCOS_was_investigated._LH_pulsatility,_androgen_concentrations,_and_hormonal_responses_to_an_oral_glucose_load_and_to_administration_of_a_GnRH_agonist_(buserelin)_were_measured_before_and_after_7_days'_treatment_with_sandostatin_100_micrograms_subcutaneously_twice_a_day_in_10_amenorrhoeic_women_with_classic_features_of_PCOS._Sandostatin_significantly_reduced_integrated_LH_concentrations_and_LH_pulse_amplitudes,_oestradiol,_testosterone,_and_androstenedione_concentrations,_and_LH_responses_to_buserelin;_it_also_suppressed_insulin_and_C-peptide_responses_to_an_oral_glucose_load._Thus_sandostatin_inhibits_pituitary_and_ovarian_hormonal_responses_in_part_by_a_direct_influence_on_pituitary_activity,_and_the_possibility_of_an_indirect_effect_mediated_by_changes_in_insulin_concentrations_requires_investigation._These_findings_have_implications_for_the_treatment_of_infertility_in_women_with_PCOS.